1. CTNI-13. A FIRST-IN-HUMAN PHASE 0/1 TRIAL OF 5-AMINOLEVULINIC ACID SONODYNAMIC THERAPY (5-ALA SDT) IN RECURRENT GLIOBLASTOMA. (14th November 2022) Authors: Sanai, Nader; Tien, An-Chi; Tovmasyan, Artak; Chang, Yu-Wei; Margaryan, Tigran; Hendrickson, Kristen; Eschbacher, Jennifer; Yoo, Wonsuk; Harmon, Jocelyn; Hong, Amy; Quarles, Christopher; Barani, Igor; Alhilali, Lea; Mirzadeh, Zaman; Mehta, Shwetal Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗